Literature DB >> 18882133

Pharmacologic comparison of the optical isomers of methadon.

C C SCOTT, E B ROBBINS, K K CHEN.   

Abstract

Entities:  

Keywords:  METHADON

Mesh：

Substances：

Year:  1948        PMID： 18882133

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN： 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  20 in total

1.  Population pharmacokinetics of (R)-, (S)- and rac-methadone in methadone maintenance patients.

Authors:  David J R Foster; Andrew A Somogyi; Jason M White; Felix Bochner
Journal:  Br J Clin Pharmacol       Date:  2004-06       Impact factor: 4.335

2.  Stereo-selective metabolism of methadone by human liver microsomes and cDNA-expressed cytochrome P450s: a reconciliation.

Authors:  Yan Chang; Wenfang B Fang; Shen-Nan Lin; David E Moody
Journal:  Basic Clin Pharmacol Toxicol       Date:  2010-09-02       Impact factor: 4.080

Review 3.  A review of pharmacological interactions between HIV or hepatitis C virus medications and opioid agonist therapy: implications and management for clinical practice.

Authors:  R Douglas Bruce; David E Moody; Frederick L Altice; Marc N Gourevitch; Gerald H Friedland
Journal:  Expert Rev Clin Pharmacol       Date:  2013-05       Impact factor: 5.045

4.  Disruption of the Na+ ion binding site as a mechanism for positive allosteric modulation of the mu-opioid receptor.

Authors:  Kathryn E Livingston; John R Traynor
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-08       Impact factor: 11.205

Review 5.  Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence.

Authors:  Chin B Eap; Thierry Buclin; Pierre Baumann
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

6.  The acute disposition of (R)- and (s)-methadone in brain and lung of sheep.

Authors:  David J R Foster; Richard N Upton; Andrew A Somogyi; Cliff Grant; Allison Martinez
Journal:  J Pharmacokinet Pharmacodyn       Date:  2005-08       Impact factor: 2.745

7.  Evaluation of an enzyme immunoassay for the detection of methadone metabolite EDDP [2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine] in urine.

Authors:  Carl E Wolf; Ashley Goldstein; Justin L Poklis; Alphonse Poklis
Journal:  J Clin Lab Anal       Date:  2014-01-06       Impact factor: 2.352

8.  Assessment of drug-drug interactions between daclatasvir and methadone or buprenorphine-naloxone.

Authors:  T Garimella; R Wang; W-L Luo; P Wastall; H Kandoussi; M DeMicco; R D Bruce; C Hwang; R Bertz; M Bifano
Journal:  Antimicrob Agents Chemother       Date:  2015-06-29       Impact factor: 5.191

9.  Activation of µ-opioid receptors and block of Kir3 potassium channels and NMDA receptor conductance by L- and D-methadone in rat locus coeruleus.

Authors:  Aya Matsui; John T Williams
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

10.  Route of administration influences substitution patterns in rats trained to discriminate methadone vs. vehicle.

Authors:  Robert E Vann; Laura E Wise; Stephen A Varvel; Scott D Philibin; D Matthew Walentiny; Joseph H Porter
Journal:  Drug Alcohol Depend       Date:  2009-05-14       Impact factor: 4.492
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.